Management of immune thrombocytopenia in women: current standards and special considerations

References

• Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood. 2017 May 25;129(21):2829–2835.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009 Mar 12;113(11):2386–2393.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F. Is ITP a thrombophilic disorder? Am J Hematol. 2016 Jan;91(1):39–45.
   PubMed Web of Science ®Google Scholar
• Moulis G, Palmaro A, Montastruc JL, et al. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014 Nov 20;124(22):3308–3315.
   PubMed Web of Science ®Google Scholar
• Terrell DR, Beebe LA, Vesely SK, et al. The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol. 2010 Mar;85(3):174–180.
   PubMed Web of Science ®Google Scholar
• Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017 Feb 09;6(2):16.
   PubMed Web of Science ®Google Scholar
• Ghanima W, Cooper N, Rodeghiero F, et al. Thrombopoietin receptor agonists: ten years later. Haematologica. 2019 May 9;104:1112–1123.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP. Br J Haematol. 2018 Apr;181(2):183–195.
   PubMed Web of Science ®Google Scholar
• Care A, Pavord S, Knight M, et al. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study. BJOG. 2018 Apr;125(5):604–612.
   PubMed Web of Science ®Google Scholar
• Loustau V, Debouverie O, Canoui-Poitrine F, et al. Effect of pregnancy on the course of immune thrombocytopenia: a retrospective study of 118 pregnancies in 82 women. Br J Haematol. 2014 Sep;166(6):929–935.
   PubMed Web of Science ®Google Scholar
• Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. J Thromb Haemost. 2008 Apr;6(4):711–712. author reply 713.
   PubMed Web of Science ®Google Scholar
• Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993 Nov 11; 329(20):1463–1466.
   PubMed Web of Science ®Google Scholar
• Boehlen F, Hohlfeld P, Extermann P, et al. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000 Jan;95(1):29–33.
   PubMed Web of Science ®Google Scholar
• Sainio S, Kekomaki R, Riikonen S, et al. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand. 2000 Sep;79(9):744–749.
   PubMed Web of Science ®Google Scholar
• Reese JA, Peck JD, McIntosh JJ, et al. Platelet counts in women with normal pregnancies: A systematic review. Am J Hematol. 2017 Nov;92(11):1224–1232.
   PubMed Web of Science ®Google Scholar
• George JN, McIntosh JJ, Reese JA. Platelet counts during pregnancy. N Engl J Med. 2018 Oct 18; 379(16):1581–1582.
   PubMed Web of Science ®Google Scholar
• Gernsheimer TB. Thrombocytopenia in pregnancy: is this immune thrombocytopenia or …? Hematology Am Soc Hematol Educ Program. 2012;2012:198–202.
   PubMed Web of Science ®Google Scholar
• Cines DB, Levine LD. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2017 Dec 8; 2017(1):144–151.
   PubMed Web of Science ®Google Scholar
• Webert KE, Mittal R, Sigouin C, et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 2003 Dec 15;102(13):4306–4311.
   PubMed Web of Science ®Google Scholar
• Gray R, Quigley MA, Hockley C, et al. Caesarean delivery and risk of stillbirth in subsequent pregnancy: a retrospective cohort study in an English population. BJOG. 2007 Mar;114(3):264–270.
   PubMed Web of Science ®Google Scholar
• Fujimura K, Harada Y, Fujimoto T, et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol. 2002 May;75(4):426–433.
   PubMed Web of Science ®Google Scholar
• Hauschner H, Rosenberg N, Seligsohn U, et al. Persistent neonatal thrombocytopenia can be caused by IgA antiplatelet antibodies in breast milk of immune thrombocytopenic mothers. Blood. 2015 Jul 30;126(5):661–664.
   PubMed Web of Science ®Google Scholar
• Sun D, Shehata N, Ye XY, et al. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. Blood. 2016 Sep 8;128(10):1329–1335.
   PubMed Web of Science ®Google Scholar
• James AH. Paving the way for improved management of severe immune thrombocytopenia purpura in pregnancy. BJOG. 2018 Apr;125(5):613.
   PubMed Web of Science ®Google Scholar
• Samuels P, Bussel JB, Braitman LE, et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med. 1990 Jul 26;323(4):229–235.
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14;115(2):168–186.
   PubMed Web of Science ®Google Scholar
• Neunert C, Lim W, Crowther M, et al. The American society of hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011 Apr 21;117(16):4190–4207.
   PubMed Web of Science ®Google Scholar
• Mathias SD, Bussel JB, George JN, et al. A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes. 2007 Feb 22;5:11.
   PubMed Web of Science ®Google Scholar
• Wang X, Xu Y, Luo W, et al. Thrombocytopenia in pregnancy with different diagnoses: differential clinical features, treatments, and outcomes. Medicine (Baltimore). 2017 Jul;96(29):e7561.
   PubMed Web of Science ®Google Scholar
• George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American society of hematology. Blood. 1996 Jul 1;88(1):3–40.
   PubMed Web of Science ®Google Scholar
• Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019 Nov 26;3(22):3780–3817.
   PubMed Web of Science ®Google Scholar
• Alami Z, Agier MS, Ahid S, et al. Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie. 2018 May - Jun;73(3):199–207.
   PubMed Web of Science ®Google Scholar
• van Veen JJ, Nokes TJ, Makris M. The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals. Br J Haematol. 2010 Jan;148(1):15–25.
   PubMed Web of Science ®Google Scholar
• Kong Z, Qin P, Xiao S, et al. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. Blood. 2017 Aug 31;130(9):1097–1103.
   PubMed Web of Science ®Google Scholar
• Pradat P, Robert-Gnansia E, Di Tanna GL, et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol. 2003 Dec;67(12):968–970.
   PubMed Web of Science ®Google Scholar
• Bjorn AM, Nielsen RB, Norgaard M, et al. Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study. Clin Epidemiol. 2013;5:287–294.
   PubMedGoogle Scholar
• Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod. 1997 Sep;2(3):129–132.
   PubMedGoogle Scholar
• Ostesen M. Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet. 1994 Dec;27(6):486–503.
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol. 2012 Jul;158(1):16–29.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA. Second malignancies after chemotherapy. In: Perry MC, editor. The chemotherapy sourcebook. Baltimore: Williams and Wilkins; 1992. p. 689.
   Google Scholar
• Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol. 1989 Oct;16(5):337–346.
   PubMed Web of Science ®Google Scholar
• Nplate product information: european medicine agency. 2019 [cited 2019 Dec 5]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/nplate#product-information-section.
   Google Scholar
• Revolade product information: european medicine agency. 2019 [cited 2019 Dec 5]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/revolade#product-information-section.
   Google Scholar
• Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood. 2011 Feb 3;117(5):1499–1506.
   PubMed Web of Science ®Google Scholar
• Wardrop D, Estcourt LJ, Brunskill SJ, et al. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst Rev. 2013 Jul;29(7):CD009733.
   Google Scholar
• Antifibrinolytic medicines: european medicine agency. 2013 [cited 2019 Dec 5]. Available from: https://www.ema.europa.eu/en/documents/referral/antifibrinolytic-medicines-article-31-referral-annex-iii-tranexamic-acid_en.pdf
   Google Scholar
• Wang S, Yang R, Zou P, et al. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia. Int J Hematol. 2012 Aug;96(2):222–228.
   PubMed Web of Science ®Google Scholar
• Bussel JB, Arnold DM, Boxer MA, et al. Long-term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program. Am J Hematol. 2019 May;94(5):546–553.
   PubMed Web of Science ®Google Scholar
• Bussel J, Arnold DM, Grossbard E, et al. Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo-controlled trials. Am J Hematol. 2018 Jul;93(7):921–930.
   PubMed Web of Science ®Google Scholar
• Drug approval package: TAVALISSE (fostamatinib disodium hexahydrate): U.S. Food & drug administration. 2018 [cited 2019 Dec 5]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/209299Orig1s000TOC.cfm.
   Google Scholar
• Lee LO, Bateman BT, Kheterpal S, et al. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the multicenter perioperative outcomes group. Anesthesiology. 2017 Jun;126(6):1053–1063.
   PubMed Web of Science ®Google Scholar
• Payne SD, Resnik R, Moore TR, et al. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol. 1997 Jul;177(1):149–155.
   PubMed Web of Science ®Google Scholar
• Berlin CM, Briggs GG. Drugs and chemicals in human milk. Semin Fetal Neonatal Med. 2005 Apr;10(2):149–159.
   PubMed Web of Science ®Google Scholar
• Kelemen E, Szalay F, Peterfy M. Autoimmune (idiopathic) thrombocytopenic purpura in pregnancy and the newborn. Br J Obstet Gynaecol. 1978 Mar;85(3):239.
   PubMedGoogle Scholar
• Leissring JC, Anderson JW, Smith DW. Uptake of antibodies by the intestine of the newborn infant. Am J Dis Child. 1962 Feb;103:160–165.
   PubMedGoogle Scholar
• Martin JN Jr., Morrison JC, Files JC. Autoimmune thrombocytopenic purpura: current concepts and recommended practices. Am J Obstet Gynecol. 1984 Sep 1;150(1):86–96.
   PubMed Web of Science ®Google Scholar
• Bussel JB. Immune thrombocytopenia in pregnancy: autoimmune and alloimmune. J Reprod Immunol. 1997 Dec 15;37(1):35–61.
   PubMed Web of Science ®Google Scholar
• Kruse C, Kruse A, Watson S, et al. Patients with immune thrombocytopenia (ITP) frequently experience severe fatigue but is it under-recognized by physicians: results from the ITP world impact survey (I-WISh). Blood. 2018;132:2273.
   PubMed Web of Science ®Google Scholar
• Qaseem A, Forciea MA, McLean RM, et al. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the american college of physicians. Ann Intern Med. 2017 Jun 6;166(11):818–839.
   PubMed Web of Science ®Google Scholar
• Bussel J, Lee CS, Seery C, et al. Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration. Haematologica. 2014;99(7):1264–1271.
   PubMed Web of Science ®Google Scholar
• Marangon M, Vianelli N, Palandri F, et al. Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response. Eur J Haematol. 2017 Apr;98(4):371–377.
   PubMed Web of Science ®Google Scholar
• Neunert CE, Cooper N. Evidence-based management of immune thrombocytopenia: ASH guideline update. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018(1):568–575.
   PubMed Web of Science ®Google Scholar
• Hill QA, Newland AC. Fatigue in immune thrombocytopenia. Br J Haematol. 2015 Jul;170(2):141–149.
   PubMed Web of Science ®Google Scholar